Skip to content

The feasibility study of endoscopy combined with fluorescence laparoscopy in the treatment of early gastric cancer

The feasibility study of endoscopy combined with fluorescence laparoscopy in the treatment of early gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049121
Enrollment
Unknown
Registered
2021-07-21
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

Endoscope combined with fluorescence laparoscopy group:Local full-thickness gastrectomy + selective lymph node dissection
Laparoscopic radical gastrectomy group:Laparoscopic radical gastrectomy
Simple ESD group:ESD

Sponsors

Affiliated Cancer Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 75 years; 2.Single origin tumor; 3.Stage I gastric cancer confirmed by preoperative endoscopic ultrasonography and pathology (excluding patients with absolute indication of ESD), as follows: (1)cT1a, UL(-), undifferentiated type, >2.0mm; (2)cT1a, UL(+), undifferentiated type; (3)cT1A, UL(+), differentiated type, >3.0mm; (4)cT1b; 4.Signed informed consent; 5.Patients can receive regular follow-up visits.

Exclusion criteria

Exclusion criteria: 1.Preoperative examination suspected local or distant lymph node metastasis; 2.Complicated with serious diseases of heart and lung organs, with contraindications to anesthesia rated by ASA; 3.Patients with bleeding tendency; 4.Allergy to tracers; 5.Pregnant and lactation patients; 6.Previous abdominal surgery history; 7.Serious heart and lung diseases.

Design outcomes

Primary

MeasureTime frame
Disease specific survival rate;

Secondary

MeasureTime frame
Mortality;Overall survival rate;Recurrence rate;Lymph node metastasis rate;Incidence of metachronous gastric cancer;

Countries

China

Contacts

Public ContactChai Jie

Affiliated Cancer Hospital of Shandong First Medical University

411679791@qq.com+86 18678867800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026